Poly(ADP-Ribose) Polymerase Inhibition Reduces Reperfusion Injury After Heart Transplantation

The aim of the present study was to investigate the effects of the novel poly(ADP-ribose) polymerase (PARP) inhibitor PJ34 (N-(6-oxo-5,6-dihydro-phenanthridin-2-yl)-N, N-dimethylacetamide) on myocardial and endothelial function after hypothermic ischemia and reperfusion in a heterotopic rat heart transplantation model. After a 1-hour ischemic preservation, reperfusion was started either after application of placebo or PJ34 (3 mg/kg). The assessment of left ventricular pressure–volume relations, total coronary blood flow, endothelial function, myocardial high energy phosphates, and histological analysis were performed at 1 and 24 hours of reperfusion. After 1 hour, myocardial contractility and relaxation, coronary blood flow, and endothelial function were significantly improved and myocardial high energy phosphate content was preserved in the PJ34-treated animals. Improved transplant function was also seen with treatment with another, structurally different PARP inhibitor, 5-aminoisoquinoline. The PARP inhibitors did not affect baseline cardiac function. Immunohistological staining confirmed that PJ34 prevented the activation of PARP in the transplanted hearts. The activation of P-selectin and ICAM-1 was significantly elevated in the vehicle-treated heart transplantation group. Thus, pharmacological PARP inhibition reduces reperfusion injury after heart transplantation due to prevention of energy depletion and downregulation of adhesion molecules and exerts a beneficial effect against reperfusion-induced graft coronary endothelial dysfunction.

[1]  F. Althaus,et al.  ADP-ribosylation of proteins. Enzymology and biological significance. , 2012, Molecular biology, biochemistry, and biophysics.

[2]  C. Szabó,et al.  Myocardial Ischemic Preconditioning in Rodents Is Dependent on Poly (ADP-Ribose) Synthetase , 2001, Molecular medicine.

[3]  M. Endres,et al.  Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke. , 2001, International journal of molecular medicine.

[4]  C. Szab,et al.  Poly(ADP-ribose) polymerase activation and the pathogenesis of circulatory shock , 2000 .

[5]  C. Thiemermann,et al.  An inhibitor of poly (ADP‐ribose) synthetase activity reduces contractile dysfunction and preserves high energy phosphate levels during reperfusion of the ischaemic rat heart , 1999, British journal of pharmacology.

[6]  C. Vahl,et al.  Endothelin-A and -B antagonists protect myocardial and endothelial function after ischemia/reperfusion in a rat heart transplantation model. , 1998, Cardiovascular Research.

[7]  S. Hagl,et al.  l-Arginine: Effect on Reperfusion Injury after Heart Transplantation , 1998, World Journal of Surgery.

[8]  B. Zingarelli,et al.  Genetic disruption of poly (ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury. , 1998, Circulation research.

[9]  S. Cuzzocrea,et al.  Peroxynitrite‐induced thymocyte apoptosis: the role of caspases and poly (ADP‐ribose) synthetase (PARS) activation , 1998, Immunology.

[10]  V. Dawson,et al.  Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. , 1998, Trends in pharmacological sciences.

[11]  C. Le Page,et al.  Inhibitors of ADP-ribosylation impair inducible nitric oxide synthase gene transcription through inhibition of NF kappa B activation. , 1998, Biochemical and biophysical research communications.

[12]  S. Cuzzocrea,et al.  Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase. , 1997, Cardiovascular research.

[13]  S. Cuzzocrea,et al.  Inhibition of poly (ADP-ribose) Synthetase Attenuates Neutrophil Recruitment and Exerts Antiinflammatory Effects , 1997, The Journal of experimental medicine.

[14]  S. Cuzzocrea,et al.  Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite. , 1997, The Journal of clinical investigation.

[15]  S. Cuzzocrea,et al.  Beneficial effects of 3‐aminobenzamide, an inhibitor of poly (ADP‐ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion , 1997, British journal of pharmacology.

[16]  R. Roeder,et al.  Poly(ADP-ribose) polymerase enhances activator-dependent transcription in vitro. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[17]  G. Buckberg,et al.  Endothelial stunning and myocyte recovery after reperfusion of jeopardized muscle: a role of L-arginine blood cardioplegia. , 1997, The Journal of thoracic and cardiovascular surgery.

[18]  C. Thiemermann,et al.  Inhibition of the activity of poly(ADP ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[19]  B. Zingarelli,et al.  Role of poly-ADP ribosyltransferase activation in the vascular contractile and energetic failure elicited by exogenous and endogenous nitric oxide and peroxynitrite. , 1996, Circulation research.

[20]  M. O’connor,et al.  DNA strand breakage, activation of poly (ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. Galiñanes,et al.  Effects of cardioplegia on vascular function and the "no-reflow" phenomenon after ischemia and reperfusion: studies in the isolated blood-perfused rat heart. , 1996, The Journal of thoracic and cardiovascular surgery.

[22]  H. Kolb,et al.  Inactivation of the poly(ADP-ribose) polymerase gene affects oxygen radical and nitric oxide toxicity in islet cells , 1995, The Journal of Biological Chemistry.

[23]  C. Smith,et al.  P-selectin and ICAM-1-dependent adherence reactions: role in the genesis of postischemic no-reflow. , 1994, The American journal of physiology.

[24]  M. Komatsu,et al.  ATP-sensitive K+ channel-independent glucose action in rat pancreatic beta-cell. , 1994, The American journal of physiology.

[25]  A. M. Lefer,et al.  In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. , 1993, The Journal of clinical investigation.

[26]  L. Cohn,et al.  Improved recovery of heart transplants by combined use of oxygen-derived free radical scavengers and energy enhancement. , 1992, The Journal of thoracic and cardiovascular surgery.

[27]  M. Galiñanes,et al.  Exogenous adenosine accelerates recovery of cardiac function and improves coronary flow after long-term hypothermic storage and transplantation. , 1992, The Journal of thoracic and cardiovascular surgery.

[28]  R. Thies,et al.  Reactive oxygen injury to cultured pulmonary artery endothelial cells: mediation by poly(ADP-ribose) polymerase activation causing NAD depletion and altered energy balance. , 1991, Archives of biochemistry and biophysics.

[29]  D. Hinshaw,et al.  Oxidant injury of cells. DNA strand-breaks activate polyadenosine diphosphate-ribose polymerase and lead to depletion of nicotinamide adenine dinucleotide. , 1986, The Journal of clinical investigation.

[30]  S. J. Berger,et al.  Poly(ADP-ribose) Polymerase inhibitors preserve nicotinamide adenine dinucleotide and adenosine 5'-triphosphate pools in DNA-damaged cells: mechanism of stimulation of unscheduled DNA synthesis. , 1983, Biochemistry.

[31]  H. Kröger,et al.  Inhibition of the induction of collagenase by interleukin-1 β in cultured rabbit synovial fibroblasts after treatment with the poly(ADP-ribose)-polymerase inhibitor 3-aminobenzamide , 2004, Rheumatology International.

[32]  K. Murthy,et al.  Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation , 2001, Nature Medicine.

[33]  C. Thiemermann,et al.  Inhibitors of poly (ADP-ribose) synthetase protect rat cardiomyocytes against oxidant stress. , 1999, Cardiovascular research.

[34]  G. Grupp,et al.  Protection against hypoxia-reoxygenation in the absence of poly (ADP-ribose) synthetase in isolated working hearts. , 1999, Journal of molecular and cellular cardiology.

[35]  K. Roebuck,et al.  H2O2 and tumor necrosis factor-alpha activate intercellular adhesion molecule 1 (ICAM-1) gene transcription through distinct cis-regulatory elements within the ICAM-1 promoter. , 1995, The Journal of biological chemistry.

[36]  M. Galiñanes,et al.  Metabolic, functional, and histologic characterization of the heterotopically transplanted rat heart when used as a model for the study of long-term recovery from global ischemia. , 1991, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[37]  J. Jackson,et al.  Oxidant injury of cells. , 1987, International journal of tissue reactions.